Literature DB >> 31892603

Relevance of Vitamin D in Melanoma Development, Progression and Therapy.

Anna A Brożyna1, Robert M Hoffman2, Andrzej T Slominski3,4,5.   

Abstract

Melanoma is one of the most lethal types of skin cancer, with a poor prognosis once the disease enters metastasis. The efficacy of currently available treatment schemes for advanced melanomas is low, expensive, and burdened by significant side-effects. Therefore, there is a need to develop new treatment options. Skin cells are able to activate vitamin D via classical and non-classical pathways. Vitamin D derivatives have anticancer properties which promote differentiation and inhibit proliferation. The role of systemic vitamin D in patients with melanoma is unclear as epidemiological studies are not definitive. In contrast, experimental data have clearly shown that vitamin D and its derivatives have anti-melanoma properties. Furthermore, molecular and clinicopathological studies have demonstrated a correlation between defects in vitamin D signaling and progression of melanoma and disease outcome. Therefore, adequate vitamin D signaling can play a role in the treatment of melanoma. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Melanoma; clinical data; experimental models; pigmentation; review; vitamin D

Mesh:

Substances:

Year:  2020        PMID: 31892603      PMCID: PMC6948187          DOI: 10.21873/anticanres.13976

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  232 in total

Review 1.  Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.

Authors:  A Slominski; J Wortsman; T Luger; R Paus; S Solomon
Journal:  Physiol Rev       Date:  2000-07       Impact factor: 37.312

Review 2.  Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation.

Authors:  Andrzej T Slominski; Zorica Janjetovic; Tae-Kang Kim; Piotr Wasilewski; Sofia Rosas; Sherie Hanna; Robert M Sayre; John C Dowdy; Wei Li; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2015-01-21       Impact factor: 4.292

Review 3.  Melanin pigmentation in mammalian skin and its hormonal regulation.

Authors:  Andrzej Slominski; Desmond J Tobin; Shigeki Shibahara; Jacobo Wortsman
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

4.  Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

Authors:  Nair Lopes; Bárbara Sousa; Diana Martins; Madalena Gomes; Daniella Vieira; Luiz A Veronese; Fernanda Milanezi; Joana Paredes; José L Costa; Fernando Schmitt
Journal:  BMC Cancer       Date:  2010-09-11       Impact factor: 4.430

Review 5.  Ultraviolet radiation and cutaneous malignant melanoma.

Authors:  Chamelli Jhappan; Frances P Noonan; Glenn Merlino
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

6.  Effect of the vitamin D3 analog ILX 23-7553 on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal human fibroblasts.

Authors:  Mark K Polar; Chris Gennings; Misook Park; Mona S Gupta; David A Gewirtz
Journal:  Cancer Chemother Pharmacol       Date:  2003-04-11       Impact factor: 3.333

7.  Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.

Authors:  Markus Seifert; Martin Rech; Viktor Meineke; Wolfgang Tilgen; Jörg Reichrath
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

Review 8.  On the role of classical and novel forms of vitamin D in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Cezary Skobowiat; Michal A Zmijewski; Tae-Kang Kim; Zorica Janjetovic; Allen S Oak; Wojciech Jozwicki; Anton M Jetten; Rebecca S Mason; Craig Elmets; We Li; Robert M Hoffman; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2017-07-01       Impact factor: 4.292

9.  Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).

Authors:  Krishnaraj Mahendraraj; Christine Sm Lau; Injoon Lee; Ronald S Chamberlain
Journal:  Clin Ophthalmol       Date:  2016-10-25

Review 10.  Exploring vitamin D metabolism and function in cancer.

Authors:  Sang-Min Jeon; Eun-Ae Shin
Journal:  Exp Mol Med       Date:  2018-04-16       Impact factor: 8.718

View more
  15 in total

Review 1.  Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives.

Authors:  Andrzej T Slominski; Anyamanee Chaiprasongsuk; Zorica Janjetovic; Tae-Kang Kim; Joanna Stefan; Radomir M Slominski; Vidya Sagar Hanumanthu; Chander Raman; Shariq Qayyum; Yuwei Song; Yuhua Song; Uraiwan Panich; David K Crossman; Mohammad Athar; Michael F Holick; Anton M Jetten; Michal A Zmijewski; Jaroslaw Zmijewski; Robert C Tuckey
Journal:  Cell Biochem Biophys       Date:  2020-05-22       Impact factor: 2.194

2.  CYP11A1‑derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas.

Authors:  Andrzej T Slominski; Anna A Brożyna; Tae-Kang Kim; Mahmoud M Elsayed; Zorica Janjetovic; Shariq Qayyum; Radomir M Slominski; Allen S W Oak; Changzhao Li; Ewa Podgorska; Wei Li; Anton M Jetten; Robert C Tuckey; Edith K Y Tang; Craig Elmets; Mohammad Athar
Journal:  Int J Oncol       Date:  2022-07-01       Impact factor: 5.884

3.  Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer.

Authors:  Lizhe Zhu; Shibo Yu; Siyuan Jiang; Guanqun Ge; Yu Yan; Yuhui Zhou; Ligang Niu; Jianjun He; Yu Ren; Bin Wang
Journal:  PeerJ       Date:  2020-11-20       Impact factor: 2.984

Review 4.  Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer-Implications for Pathogenesis and Therapy.

Authors:  Janusz Blasiak; Elzbieta Pawlowska; Jan Chojnacki; Joanna Szczepanska; Michal Fila; Cezary Chojnacki
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

Review 5.  Current Molecular Markers of Melanoma and Treatment Targets.

Authors:  Kevin Yang; Allen S W Oak; Radomir M Slominski; Anna A Brożyna; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

6.  Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells.

Authors:  Diana Salvador; Verónica Bastos; Helena Oliveira
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

7.  Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial.

Authors:  Harriet Johansson; Giuseppe Spadola; Giulio Tosti; Mario Mandalà; Alessandro M Minisini; Paola Queirolo; Valentina Aristarco; Federica Baldini; Emilia Cocorocchio; Elena Albertazzi; Leonardo Zichichi; Saverio Cinieri; Costantino Jemos; Giovanni Mazzarol; Patrizia Gnagnarella; Debora Macis; Ines Tedeschi; Emanuela Omodeo Salè; Luigia Stefania Stucci; Bernardo Bonanni; Alessandro Testori; Elisabetta Pennacchioli; Pier Francesco Ferrucci; Sara Gandini
Journal:  Nutrients       Date:  2021-06-04       Impact factor: 5.717

8.  Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells.

Authors:  Ewa Podgorska; Tae-Kang Kim; Zorica Janjetovic; Krystyna Urbanska; Robert C Tuckey; Sejong Bae; Andrzej T Slominski
Journal:  Cancers (Basel)       Date:  2021-06-22       Impact factor: 6.639

9.  Epithelial differentiation of human adipose-derived stem cells (hASCs) undergoing three-dimensional (3D) cultivation with collagen sponge scaffold (CSS) via an indirect co-culture strategy.

Authors:  Minxiong Li; Jun Ma; Yanbin Gao; Mengru Dong; Zijun Zheng; Yuchen Li; Rongwei Tan; Zhending She; Lei Yang
Journal:  Stem Cell Res Ther       Date:  2020-03-31       Impact factor: 6.832

Review 10.  The Role of the Vitamin D Receptor in the Pathogenesis, Prognosis, and Treatment of Cutaneous Melanoma.

Authors:  Alyssa L Becker; Evan L Carpenter; Andrzej T Slominski; Arup K Indra
Journal:  Front Oncol       Date:  2021-10-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.